Back to search results

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE2

Conditions

Non-small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • City of Hope Comprehensive Cancer Center, Duarte, California, United States

  • City of Hope - Orange County Lennar Foundation Cancer Center, Irvine, California, United States

  • USC Norris Cancer Center, Los Angeles, California, United States

  • Cedars-Sinai Medical Center, Los Angeles, California, United States

  • University of California Los Angeles - Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

  • The Center for Cancer Prevention and Treatment at St.Joseph Hospital of Orange, Orange, California, United States

  • UC Davis Comprehensive Cancer Center, Sacramento, California, United States

  • UCSF Helen Diller Family CCC, San Francisco, California, United States

  • University of Colorado - Anschutz Medical Campus (University of Colorado Health Sciences Center), Aurora, Colorado, United States

  • Yale Cancer Center, New Haven, Connecticut, United States

  • MedStar Georgetown University Hospital (Lombardi Comprehensive Cancer Center), Washington D.C., District of Columbia, United States

  • Moffitt Cancer Center, Tampa, Florida, United States

  • Northwestern University, Chicago, Illinois, United States

  • Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States

  • Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States

  • Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States

  • Boston Medical Center, Boston, Massachusetts, United States

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

  • University of Michigan, Ann Arbor, Michigan, United States

  • Karmanos Cancer Institute - Farmington Hills/Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States

  • Mayo Clinic, Rochester, Minnesota, United States

  • Ellis Fischel Cancer Center, Columbia, Missouri, United States

  • Siteman Cancer Center - Washington University Medical Campus, St Louis, Missouri, United States

  • Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States

  • Laura and ISAAC Perlmutter Cancer Center at NYU Langone., New York, New York, United States

  • Columbia University Medical Center, New York, New York, United States

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

  • University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

  • Ohio State University, Columbus, Ohio, United States

  • AHN Cancer Institute ? Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

  • Baptist Clinical Research Institute, Memphis, Tennessee, United States

  • Tennessee Oncology - Nashville, Nashville, Tennessee, United States

  • Kelsey Seybold Clnic, Houston, Texas, United States

  • University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • Baylor College of Medicine, Houston, Texas, United States

  • Lumi Research, Kingwood, Texas, United States

  • Virginia Cancer Specialists (Fairfax) - USOR, Fairfax, Virginia, United States

  • Seattle Cancer Care Alliance, Seattle, Washington, United States

Study leads

  • Clinical Trials

    Study Director

    Hoffmann-La Roche

View source on ClinicalTrials.gov(opens in a new tab)